HPV16 Oncoproteins Induce MMPs/RECK-TIMP-2 Imbalance in Primary Keratinocytes: Possible Implications in Cervical Carcinogenesis


Autoria(s): Cardeal, Laura Beatriz da Silva; Boccardo, Enrique; Termini, Lara; Rabachini, Tatiana; Andreoli, Maria Antonieta; di Loreto, Celso; Longatto Filho, Adhemar; Villa, Luisa Lina; Engler, Silvya Stuchi Maria
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

24/09/2013

24/09/2013

01/03/2012

Resumo

Cervical cancer is the third most common cancer in women worldwide. Persistent infection with high-risk HPV types, principally HPV16 and 18 is the main risk factor for the development of this malignancy. However, the onset of invasive tumor occurs many years after initial exposure in a minority of infected women. This suggests that other factors beyond viral infection are necessary for tumor establishment and progression. Tumor progression is characterized by an increase in secretion and activation of matrix metalloproteinases (MMPs) produced by either the tumor cells themselves or tumor-associated fibroblasts or macrophages. Increased MMPs expression, including MMP-2, MMP-9 and MT1-MMP, has been observed during cervical carcinoma progression. These proteins have been associated with degradation of ECM components, tumor invasion, metastasis and recurrence. However, few studies have evaluated the interplay between HPV infection and the expression and activity of MMPs and their regulators in cervical cancer. We analyzed the effect of HPV16 oncoproteins on the expression and activity of MMP-2, MMP-9, MT1-MMP, and their inhibitors TIMP-2 and RECK in cultures of human keratinocytes. We observed that E7 expression is associated with increased pro-MMP-9 activity in the epithelial component of organotypic cultures, while E6 and E7 oncoproteins co-expression down-regulates RECK and TIMP-2 levels in organotypic and monolayers cultures. Finally, a study conducted in human cervical tissues showed a decrease in RECK expression levels in precancer and cancer lesions. Our results indicate that HPV oncoproteins promote MMPs/ RECK-TIMP-2 imbalance which may be involved in HPV-associated lesions outcome.

FAPESP-Sao Paulo Research Foundation [2005/58885-1, 2008/58817-4, 2008/03232-1]

FAPESPSao Paulo Research Foundation

PRPGUSP: ProReitoria de PosGraduacao da Universidade de Sao Paulo

PRPG-USP: Pro-Reitoria de Pos-Graduacao da Universidade de Sao Paulo

CNPq: Conselho Nacional de Pesquisa e Desenvolvimento

Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)

Identificador

PLOS ONE, SAN FRANCISCO, v. 7, n. 3, MAR 2012

1932-6203

http://www.producao.usp.br/handle/BDPI/33629

10.1371/journal.pone.0033585

http://dx.doi.org/10.1371/journal.pone.0033585

Idioma(s)

eng

Publicador

PUBLIC LIBRARY SCIENCE

SAN FRANCISCO

Relação

PLoS ONE

Direitos

openAccess

Copyright PUBLIC LIBRARY SCIENCE

Palavras-Chave #CYSTEINE-RICH PROTEIN #MATRIX-METALLOPROTEINASE #TUMOR MICROENVIRONMENT #CLINICAL-SIGNIFICANCE #CANCER PROGRESSION #TISSUE INHIBITOR #GENE-EXPRESSION #CARCINOMA CELLS #REGULATOR RECK #UTERINE CERVIX #MULTIDISCIPLINARY SCIENCES
Tipo

article

original article

publishedVersion